All content
The QbD Group acquires Turnstone Communications and BioVox to strengthen its specialist science communication and marketing services
Wilrijk/Ghent, Belgium, 25 May 2023 – The QbD Group, a privately held company offering comprehensive support to life science companies […] May 25, 2023 · Turnstone Communications
OHMX.bio: state-of-the-art omics solutions
OHMX.bio provides innovative omics solutions using state-of-the-art sequencing and mass spectrometry platforms. Specializing in expression analysis (RNA-seq and RIBO-seq) and […] May 24, 2023 · MEDVIA
Fake it till you fund it?
Silicon Valley investment gurus have long promoted the idea that startups should ‘fake it till you make it’ to become […] May 24, 2023 · V-Bio Ventures
Unlocking the potential of patient data using healthcare data standards
May 24, 2023 · Janssen PharmaceuticaV-Bio Ventures portfolio company Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic
Use of proceeds will enable the development of the Company’s lead autoimmune program DT-001, targeting TNFR2, as well as its […] May 15, 2023 · V-Bio Ventures
Corteria: a new strategy and approach to treating heart failure
Corteria Pharmaceuticals is developing transformative therapies for heart failure subpopulations most likely to benefit from the company’s novel cardiorenal treatments. […] April 25, 2023 · V-Bio Ventures
CoMoveIT: patient-driven mobility solutions for people with complex movement disorders
CoMoveIT is a striking example of how visionary ideas can be turned into life-changing innovations once the right technology becomes […] April 25, 2023 · MEDVIA
Data science: empowering animal-free progress in preclinical development
Many drugs fail clinical trials, often because preclinical animal models fall short of replicating human physiology. To improve animal welfare, […] April 25, 2023 · Janssen Pharmaceutica
Nicky Deasy: how agrifood startups can help us tackle climate change
Nicky Deasy is Co-Founder and former Managing Partner at The Yield Lab Europe, one of the largest early-stage venture capital […] April 3, 2023 · BioVox
Are we at the end of the biotech boom cycle?
Bankruptcy, closures, and layoffs – oh my! But it’s not all doom and gloom for the biotech boom. Innovation is still […] March 29, 2023 · V-Bio Ventures
eureKARE stimulates synthetic biology start-ups with studio in Belgium
With its network of thematic SynBio Studios, investment company eureKARE is boosting the creation of new European start-ups in synthetic […] March 29, 2023 · BioVox
Dosing flash radiation for the future of cancer treatment
Flash radiation has the potential to become a revolution in radiation therapy. An incredibly promising cancer treatment that limits the […] March 27, 2023 · MEDVIA